Silk Protein Technology for biologic stabilization
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
45
NCT06125717
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 2, 2022
Completion: Mar 13, 2023
Loading map...